The National Institute for Health and Care Excellence (NICE) accredited the BAD’s clinical guideline development process as a mark of quality between 2010 and 2024 before closing its accreditation programme in July 2024.

As the NICE Accreditation criteria were already largely aligned with the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument and the international gold-standard GRADE methodology for developing clinical guidelines, the BAD will continue to commit to developing its clinical guidelines according to its NICE-accredited process, described in ‘Updated guidance for writing a British Association of Dermatologists clinical guideline – the adoption of the GRADE methodology 2016’, hence observing the spirit of the accreditation scheme.